课题基金 / 基金详情

Analyses of the functions of MYPT family, novel anchoring proteins, in cardiovascular system by their knockout and transgenic mice

Analyses of the functions of MYPT family, novel anchoring proteins, in cardiovascular system by their knockout and transgenic mice
通过敲除小鼠和转基因小鼠分析新型锚定蛋白 MYPT 家族在心血管系统中的功能
批准号:
12470152
负责人:
NAKANO Takeshi
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

NAKANO Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
MYPT is a target subunit of myosin phosphates (MP), in which MYPT interacts with a catalytic subunit (PP 1 cδ) and the other regulatory subunit, M20. MYPT could also interact with other molecules including RhoA and cGMP-dependent protein kinase Iα, indicating that MYPT has a role as an anchoring protein. MYPT1 is a target subunit of smooth muscle/nonmuscle MP and MYPT2 is that of cardiac/skeletal muscle MP. To investigate the in vivo function of MYPTs, we generated MYPT1-deficient mice and MYPT2 transgenic mice, and analyzed these phenotypesThe heterozygous of MYPT1-deficient mice showed no changes in the expression levels of MYPT1 and no phenotypes as compared with those in the wild type mice, however, none of the F2 mice was homozygous for the MYPT1 deletion, indicating that the targeted disruption of the MYPT1 gene results in embryonic lethality. The point of embryonic lethality is considered to be before 7.5 dpc. These findings indicate that MYPT1 is essential for mouse embryogenes … More isThe transgenic mice overexpressing MYPT2 (Tg) using α-MHC promoter demonstrated a significantly increased expression of MYPT2 (>20 folds) specifically in hearts with a concomitant increase of the endogenous PP1cδ. The phosphorylation levels of regulatory myosin light chain (RLC) in Tg were significantly lower than those in the wild type mice (Wt). These results suggest the specific in vivo interaction of MYPT2 with PP1cδ, which could dephosphorylate RLC in heart. Survival rate, body weight, heart rate and blood pressure were not significantly different between Tg and Wt. Heart weight/body weight ratio of Tg was significantly higher than that of Wt. Echocardiography demonstrated the dilation of LU dimension (LVDd and LVDs) and the moderate impairment of LV function in Tg. These results suggest that the overexpression of MYPT2 and the concomitant increased MP activity decreased LV contractility, resulting in mild LV dilatation. Taken together, MP seems to play a role in cardiac function in vivo Less
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
Shigemasa Araki: "Arachidonic acid-induced Ca^<2+> sensitization of smooth muscle contraction through activation of Rho-kinase"Pflugers Archiv.Eur.J.Physiol.. 441. 596-603 (2001)
Shigemasa Araki:“通过Rho激酶的激活,花生四烯酸诱导的Ca ^ 2 > 平滑肌收缩的敏化”Pflugers Archive.Eur.J.Physiol.. 441. 596-603 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takafumi Koji: "Addition of angiotensin II receptor antagonist to ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanism"J.Cardiovasc.Pharmacol.. 41. 632-639 (2003)
Takafumi Koji:“在心力衰竭中添加血管紧张素 II 受体拮抗剂至 ACE 抑制剂可通过缓激肽介导的机制改善心血管功能”J.Cardiovasc.Pharmacol.. 41. 632-639 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Harold Shirato, Hiroshi Shima, Gyosuke Sakashita, Takeshi Nakano, Masaaki Ito, Ernest Y C.Lee, Kunimi Kikuchi: "Identification and characterization of a novel protein inhibitor of type-1 protein phosphatase"Biochemistry. 39. 13848-13855 (2000)
Harold Shirato、Hiroshi Shima、Gyosuke Sakashita、Takeshi Nakano、Masaaki Ito、Ernest Y C.Lee、Kunimi Kikuchi:“1 型蛋白磷酸酶新型蛋白抑制剂的鉴定和表征”生物化学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Testuya Seko: "Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular Smooth muscle"Circulation Research. 92. 411-418 (2003)
Testuya Seko:“RhoA 的激活和肌球蛋白磷酸酶的抑制是血管平滑肌高血压的重要组成部分”循环研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Reform of the Civil Code and Theory of Administrative Law
    • 批准号:
      26380032
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2014
    • 负责人:
      NAKANO Takeshi
    • 依托单位:
    Theoretical Analysis of Legislative Drafting by Cabinet Legislative Bureau
    Comprehensive Research on Japanese Substantive Administrative Law-focused on the standing of the two types of injunctive actions
    • 批准号:
      18730015
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.5万
    • 财政年份:
      2006
    • 负责人:
      NAKANO Takeshi
    • 依托单位:
    Molecular mechanism of plant of development regulation by progesterone
    国内基金
    海外基金
    AMPK 通过 MYPT1 调控磷脂代谢改善血管内皮细胞凝血功能缓解脓毒症肺损 伤的机制研究
    MYPT1调控糖脂代谢影响前列腺癌细胞骨架的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2021
    • 负责人:
      李茂章
    • 依托单位:
    血管平滑肌细胞中膜钙泵PMCA与肌球蛋白轻链磷酸酶引导亚单位MYPT1的互作在血管张力调节及高血压病理发生中的作用
    • 批准号:
      82070443
    • 项目类别:
      面上项目
    • 资助金额:
      54.0万元
    • 批准年份:
      2020
    • 负责人:
      陈洁
    • 依托单位:
    阴茎动脉血管中MYPT1表达异常导致勃起功能障碍的机制研究
    • 批准号:
      82001535
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      赵薇
    • 依托单位: